Drug approval could signal new era in Hepatitis C treatment.
Proposal strictly defines home and community-based care.
A rare strain of E. coli raises tensions and questions over the EU response.
The law requires abortion clinics to meet stringent standards.
HHS repeals “overly broad” portions of Bush-era regulation.
New product safety initiative receives mixed reviews.
Proposed standards attempt to reduce black lung disease risk.
Senators debate whether to regulate a drilling process.
New National Center for Advancing Translational Sciences works with pharmaceutical companies to develop drugs.
The Supreme Court decides that federal statutes preempt state lawsuits over vaccinations.
The FDA proposes to withdraw approval for a breast cancer treatment, with hearing scheduled for June.
The FDA holds public meetings to discuss its new authority as some members of Congress question the agency’s budget.